Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

Key appointment to lead global commercial launch of eProtein Discovery platform

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model

New Cambridge CF firm advises on sale of Cambridge based Cogentia Healthcare Consulting to Helios Global Group

Alfa Corporate Finance advises on sale of HEOR and market access specialist Cogentia Healthcare Consulting to Helios Global Group

Addenbrooke’s Charity supporters have raised over £100,000 for the new Cambridge Cancer Research Hospital in just one weekend

Earlier this month, Addenbrooke’s Charitable Trust’s (ACT) amazing supporters pulled out all the stops with three magnificent fundraising events raising more than £100,000 for the new Cambridge Cancer Research Hospital.

Shining a light on the future of business: The Guildhall to light up for B Corp Month this March

Between 13 and 20 March, The Guildhall, in Cambridge City’s Market Square, will light up in white, yellow and pink to celebrate B Corp Month, which takes place throughout March.

Arecor and TRx Biosciences establish research collaboration to develop Oral Glp-1 with enhanced bioavailability

Companies to combine proprietary technologies to formulate an oral semaglutide (GLP-1 receptor agonist) product with enhanced bioavailability Collaboration focused on overcoming the challenges of oral peptide delivery using a novel lipid technology to provide a more convenient t

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa study

Cambridgeshire and Belfast, UK: Exploristics, a world-leading provider of biosimulat

5 tips for managing your career in 2024

How can you get ahead in your career in this unpredictable, ever-evolving world? There will always be things that throw us off course – the pandemic being a good example. But there are steps we can take to help us navigate these bumpy roads.

Where are the practical and responsible people-centred applications of artificial intelligence in real-world learning and development?

In a recent webinar, Acteon’s Matt Borg explored how making smart use of AI can help provide colleagues with customised learning plans, personalised coaching and just-in-time micro content.

(Image removed)

Metrion Biosciences strengthens team with three key appointments

Clare Rutty promoted to CFO, Sue Peffer appointed Head of Marketing, Leanne Clarke appointed HR Officer.

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics

Guardtech Group to deliver design masterclass at Cleanroom Technology webinar series

Suffolk-based cleanroom construction specialists to provide best practice advice at online Design & Build forum for industry experts

Business Improvement - Free consulting

Evolue Ltd writes...Exciting News: We’re offering a free consultation to help you accelerate your business. Following our recent announcement of the launch of Evolue [https://www.cambridgenetwork.co.uk/news/launching-evolue-hello-world], we want to showcase the unique value we bring by offering a free consultation session that will inspire the needed change for you and your business to evolve.

Yasmin Islam joins Salus Wellness this month

The team are happy to announce that Yasmin Islam has joined Salus Wellness. Yasmin Islam is an adult nurse registered with the Nursing and Midwifery Council (NMC). She has developed her passion for aesthetic treatments and specialises in non-surgical facial beautification and rejuvenation with the use of dermal fillers, anti-wrinkle injections and fat-dissolving treatments.

Beyond sleep apps: The power of human support in insomnia recovery

Salus Wellness Clinics writes...In the quest for better sleep, a myriad of digital solutions beckon, promising relief from restless nights. Yet, amidst the allure of sleep apps and digital platforms, the age-old remedy of human support shines bright, offering personalized guidance and steadfast empathy in the journey toward better sleep.

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications Data generated fully support continued clinical development of EXN407 into the CLEAR-DM Phase IIb study

Consultant led Cyber Essentials certification

Still considering if Cyber Essentials or Cyber Essentials Plus is the right certification for your business?

SolasCure publishes Phase IIa Clinical Trial Report in leading Wound Care Journal

Publication in the ‘International Wound Journal’ provides robust validation of the Phase IIa trial data that will enable further clinical studies Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic woun

Transforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare

In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge.

SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction

The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours.

Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production

Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production

2024 Corazon's Charity of the Year

Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees.

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery

CRA Insights: A landscape assessment of newborn screening (NBS) in Europe

Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized pati

Jon Hume joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.